Aung Pyae Phyo, a Burmese (Myanmar) clinician, finished his medical training in 2001, joined Shoklo Malaria Research Unit (Maesot, Thailand) in 2005 and has done a number of trials in malaria particularly on drug resistance. He finished DPhil at Oxford and his research interest is the epidemiology of infectious diseases, management and elimination of drug resistant malaria.
He was awarded an international fellowship from the Wellcome Trust to study the impact of mass drug administration for malaria elimination on the population immunity & long term incidence of malaria. ACREME has supported to conduct “Field evaluation of a Point-of-Contact device for P. falciparum malaria sero-surveillance” nested into his main research project.
Projects
· Multiple micronutrients plus higher doses of vitamins A, C, D and zinc to address deficiencies and support tuberculosis treatment in a resource-poor setting
· Immunogenicity of the Janssen Ad26.COV2.S COVID-19 vaccine against Coronavirus Disease (COVID-19) among Tuberculosis patients in Thailand-Myanmar border
· Impact of malaria elimination on immunity and risk of malaria rebound in Myanmar (2020-2022)
· Malaria Elimination in Karen state (2014-2020)
· Defining the optimal management of P. falciparum malaria on a background of emerging artemisinin combination therapy resistance on the Thai-Myanmar Border (2013-2017)
